
Waymond D. Bray
Examiner (ID: 831)
| Most Active Art Unit | 3201 |
| Art Unit(s) | 3725, 2899, 3204, 3201, 3203 |
| Total Applications | 3197 |
| Issued Applications | 3049 |
| Pending Applications | 43 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 10/840737 | Methods and compositions for inhibiting the proliferation of cancer cells | May 5, 2004 | Abandoned |
Array
(
[id] => 7025524
[patent_doc_number] => 20050019918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Treatment of cancer by inhibiting BRAF expression'
[patent_app_type] => utility
[patent_app_number] => 10/834665
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5869
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834665 | Treatment of cancer by inhibiting BRAF expression | Apr 28, 2004 | Abandoned |
Array
(
[id] => 4995123
[patent_doc_number] => 20070010468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Methods and compositions for the inhibition of stat5 in prostate cancer cells'
[patent_app_type] => utility
[patent_app_number] => 10/554123
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12588
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554123 | Methods and compositions for the inhibition of stat5 in prostate cancer cells | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7063718
[patent_doc_number] => 20050005314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'ALK protein tyrosine kinase, cells and methods embodying and using same'
[patent_app_type] => utility
[patent_app_number] => 10/830877
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23081
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20050005314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830877 | ALK protein tyrosine kinase, cells and methods embodying and using same | Apr 22, 2004 | Issued |
Array
(
[id] => 7061043
[patent_doc_number] => 20050003404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Telomerase interference'
[patent_app_type] => utility
[patent_app_number] => 10/831266
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7582
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831266
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831266 | Telomerase interference | Apr 21, 2004 | Abandoned |
Array
(
[id] => 6967097
[patent_doc_number] => 20050233994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Methods and vectors for expressing siRNA'
[patent_app_type] => utility
[patent_app_number] => 10/826130
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11451
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826130 | Methods and vectors for expressing siRNA | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7122851
[patent_doc_number] => 20050014680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Methods and compositions for enhancing neuron growth and survival'
[patent_app_type] => utility
[patent_app_number] => 10/824939
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22499
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824939 | Methods and compositions for enhancing neuron growth and survival | Apr 14, 2004 | Abandoned |
Array
(
[id] => 5648907
[patent_doc_number] => 20060134639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Method for the determination of cellular transcriptional regulation'
[patent_app_type] => utility
[patent_app_number] => 10/818956
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9854
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818956 | Method for the determination of cellular transcriptional regulation | Apr 5, 2004 | Abandoned |
Array
(
[id] => 5000348
[patent_doc_number] => 20070042982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL REGULATORY BACTERIAL AND BACTERIAL ASSOCIATED OLIGONUCLEOTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 10/708951
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20248
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10708951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/708951 | Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof | Apr 1, 2004 | Issued |
Array
(
[id] => 5041153
[patent_doc_number] => 20070093435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Modulation of cell phenotype by inhibitory rna'
[patent_app_type] => utility
[patent_app_number] => 10/550499
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9499
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550499 | Modulation of cell phenotype by inhibitory rna | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7083149
[patent_doc_number] => 20050048529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/800487
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 59708
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800487 | RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7168584
[patent_doc_number] => 20050202075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers'
[patent_app_type] => utility
[patent_app_number] => 10/800362
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11262
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800362 | Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers | Mar 11, 2004 | Abandoned |
Array
(
[id] => 7195724
[patent_doc_number] => 20050164212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Modulation of gene expression using DNA-RNA hybrids'
[patent_app_type] => utility
[patent_app_number] => 10/793425
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8866
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793425
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793425 | Modulation of gene expression using DNA-RNA hybrids | Mar 3, 2004 | Abandoned |
Array
(
[id] => 7316679
[patent_doc_number] => 20040223952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Generation and/or reduction of new lung tissue in an affected lung'
[patent_app_type] => new
[patent_app_number] => 10/250954
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10270
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250954 | Generation and/or reduction of new lung tissue in an affected lung | Feb 19, 2004 | Abandoned |
Array
(
[id] => 7138017
[patent_doc_number] => 20050182004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Modulation of DC-SIGN expression'
[patent_app_type] => utility
[patent_app_number] => 10/776478
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24670
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776478 | Modulation of DC-SIGN expression | Feb 10, 2004 | Abandoned |
Array
(
[id] => 6939761
[patent_doc_number] => 20050113324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Modulation of line-1 reverse transcriptase'
[patent_app_type] => utility
[patent_app_number] => 10/758329
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11921
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758329
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758329 | Modulation of line-1 reverse transcriptase | Jan 14, 2004 | Abandoned |
Array
(
[id] => 7317534
[patent_doc_number] => 20040224328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'siRNA screening method'
[patent_app_type] => new
[patent_app_number] => 10/754588
[patent_app_country] => US
[patent_app_date] => 2004-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6758
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754588 | siRNA screening method | Jan 11, 2004 | Abandoned |
Array
(
[id] => 7088928
[patent_doc_number] => 20050009041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Peptide nucleic acids and synthetic procedures therefor'
[patent_app_type] => utility
[patent_app_number] => 10/755118
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 52931
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10755118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/755118 | Peptide nucleic acids and synthetic procedures therefor | Jan 8, 2004 | Abandoned |
Array
(
[id] => 5672971
[patent_doc_number] => 20060178326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Ribozyme therapy for the treatment of proliferative skin and eye diseases'
[patent_app_type] => utility
[patent_app_number] => 10/753718
[patent_app_country] => US
[patent_app_date] => 2004-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11986
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753718 | Ribozyme therapy for the treatment of proliferative skin and eye diseases | Jan 7, 2004 | Abandoned |
Array
(
[id] => 7441182
[patent_doc_number] => 20040185500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Use of disease-associated gene'
[patent_app_type] => new
[patent_app_number] => 10/482669
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19777
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482669 | Use of disease-associated gene | Dec 30, 2003 | Abandoned |